Romain Remark

机构：Mount Sinai Hospital

发表论文 123 篇 · 总被引 11465 次 · h-index 29

代表论文

• Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers (2023 · Cellular and Molecular Immunology · 被引 39)
• A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma (2024 · Science Immunology · 被引 19)
• A phase 1, open-label, multi-center study of the safety, tolerability, and efficacy of IPH4502 as a single agent in advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 3)
• Preclinical assessment of IPH6501, a first-in-class IL2v-armed tetraspecific NK cell engager directed against CD20 for R/R B-NHL, in comparison with a CD20-targeting T cell engager. (2024 · Journal of Clinical Oncology · 被引 2)
• Abstract 6582: Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors (2024 · Cancer Research · 被引 2)
• S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS (2023 · HemaSphere · 被引 2)